Back

Risk of restenosis for in-stent restenosis and de novo lesions treated during the same percutaneous coronary intervention procedure

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Doruntina Lahu

(Germany)

5 More presentations in this session

Presentation thumbnail
Use of colchicine after coronary artery stenting: results of one-year follow-up
Doctor S. Akhmedov (Tashkent, UZ)
Presentation thumbnail
Outcome of left main stent implantation: a randomized comparison between ultra-thin strut (Suprafex Cruz) and thin strut (SYNERGY) stent, a post-hoc sub-analysis of the Multivessel TALENT trial
Doctor N. Kanehama (Galway, IE)
Abstract Slides
Presentation thumbnail
Long term outcomes after ostial/proximal left circumflex coronary artery percutaneous intervention: the role of geographical miss and stent underexpansion.
Professor R. Abo Fanne (Hadera, IL)
Presentation thumbnail
Safety and efficacy of drug-eluting balloons in large coronary vessels: a lesion-level analysis of real-world PCI practice
Doctor L. Hamann (Faro, PT)
Abstract Slides
Presentation thumbnail
Comparison of two different paclitaxel-coated balloons in small native coronary vessel disease
Professor W. Kang (KR)

Access the full session

Session thumbnail
Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Restenosis after drug-coated balloon therapy for in-stent restenosis: an overview of case findings
1 September 2025
thumbnail
Congress Presentation
Unprotected left main coronary artery stenting: true vs. non true bifurcation lesions; a single-centre experience
27 August 2021
thumbnail
Congress Presentation
Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials
28 August 2020
thumbnail
Congress Presentation
Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources